Alibi Idris posted a screenshot of correspondence with the UFC's anti-doping agency to his social media stories following news of a failed drug test. The screenshot shows communication from the anti-doping agency indicating that a test provided on March 16 came back clean. The post appears to be Idris's response to allegations or reports about prohibited substances in his system. The post provides limited details about the nature of the initial failed test or the specific substances involved, focusing instead on showing evidence of a subsequent clean result.
Alibi Idris took to social media to push back against reports of a failed drug test, posting a screenshot of correspondence from the UFC's anti-doping agency that he says shows a clean result.
The screenshot, shared to Idris's social media stories, displays communication from the anti-doping body confirming that a sample he provided on March 16 returned no adverse finding. The post appears to be a direct response to circulating reports that the fighter had tested positive for a prohibited substance, though Idris offered limited explanation of the broader situation surrounding those initial allegations.
Why it matters
- The post does not address the nature or timing of the originally reported failed test, leaving key questions unanswered.
- A single clean result does not necessarily resolve an anti-doping case, as agencies typically evaluate the full body of testing history before reaching a determination.
- The situation remains unclear, with no official statement from the UFC or its anti-doping partner providing a complete account of where the case currently stands.
Because the correspondence shown covers only the March 16 sample, the gap between that result and whatever prompted the initial failed-test reports has not been publicly explained. No verified fighter data was available for Idris in the AgentMMA database at the time of publication, and neither the UFC nor its anti-doping agency had issued a formal public comment on the matter as of April 7.







